BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 3,215.00
+35.00 (1.10%)
Jul 1, 2026, 3:30 PM KST
BCWORLD PHARM. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,329 | 51,146 | 43,349 | 54,513 | 71,475 | 135,336 | |
Market Cap Growth | -25.74% | 17.99% | -20.48% | -23.73% | -47.19% | -32.84% |
Enterprise Value | 116,885 | 132,008 | 121,862 | 135,074 | 157,092 | 213,472 |
Last Close Price | 3180.00 | 5510.00 | 4169.91 | 5137.48 | 6632.03 | 12266.12 |
PE Ratio | - | - | - | 20.70 | 254.09 | - |
PS Ratio | 0.41 | 0.68 | 0.58 | 0.73 | 0.98 | 2.18 |
PB Ratio | 0.45 | 0.71 | 0.57 | 0.68 | 0.92 | 1.70 |
P/TBV Ratio | 0.47 | 0.74 | 0.59 | 0.69 | 0.93 | 1.71 |
P/FCF Ratio | - | 32.19 | 26.36 | 6.52 | 107.29 | - |
P/OCF Ratio | 14.90 | 9.17 | 10.72 | 4.98 | 10.38 | - |
EV/Sales Ratio | 1.46 | 1.74 | 1.63 | 1.80 | 2.16 | 3.44 |
EV/EBITDA Ratio | 9.30 | 13.27 | 13.26 | 9.76 | 17.32 | 58.64 |
EV/EBIT Ratio | 25.99 | 66.12 | 81.25 | 21.22 | 84.38 | - |
EV/FCF Ratio | - | 83.07 | 74.11 | 16.16 | 235.80 | - |
Debt / Equity Ratio | 1.21 | 1.20 | 1.17 | 1.15 | 1.22 | 1.12 |
Debt / EBITDA Ratio | 6.95 | 8.76 | 9.68 | 6.64 | 10.39 | 24.45 |
Debt / FCF Ratio | - | 54.85 | 54.10 | 10.99 | 141.48 | - |
Net Debt / Equity Ratio | 1.15 | 1.11 | 1.07 | 1.01 | 1.11 | 1.06 |
Net Debt / EBITDA Ratio | 6.60 | 8.08 | 8.82 | 5.83 | 9.50 | 23.22 |
Net Debt / FCF Ratio | -30.85 | 50.57 | 49.29 | 9.65 | 129.38 | -4.68 |
Asset Turnover | 0.46 | 0.43 | 0.42 | 0.41 | 0.40 | 0.35 |
Inventory Turnover | 2.30 | 2.50 | 2.93 | 2.55 | 2.76 | 2.68 |
Quick Ratio | 0.27 | 0.30 | 0.34 | 0.33 | 0.31 | 0.37 |
Current Ratio | 0.56 | 0.55 | 0.52 | 0.52 | 0.52 | 0.67 |
Return on Equity (ROE) | -0.66% | -4.23% | -4.25% | 3.67% | 0.08% | -3.65% |
Return on Assets (ROA) | 1.62% | 0.71% | 0.52% | 2.17% | 0.64% | -0.54% |
Return on Invested Capital (ROIC) | -2.57% | 1.29% | 0.95% | 3.93% | 1.14% | -1.30% |
Return on Capital Employed (ROCE) | 5.10% | 2.30% | 1.70% | 6.90% | 1.90% | -1.20% |
Earnings Yield | -7.76% | -9.57% | -10.22% | 4.83% | 0.39% | -1.36% |
FCF Yield | -8.31% | 3.11% | 3.79% | 15.34% | 0.93% | -13.35% |
Payout Ratio | - | - | - | 20.61% | 303.55% | - |
Buyback Yield / Dilution | -0.18% | -0.19% | 9.18% | 0.98% | 0.19% | -0.35% |
Total Shareholder Return | 2.60% | -0.19% | 9.18% | 0.98% | 0.19% | -0.35% |